VIGL vs. VIVAX

In the year-to-date period, VIGL achieves a 363.53% return, which is significantly higher than VIVAX's 1.63% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Vigil Neuroscience, Inc. (VIGL) and Vanguard Value Index Fund (VIVAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current VIGL Sharpe Ratio is 0.64, which is comparable to the VIVAX Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of VIGL and VIVAX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

VIGL has not paid dividends to shareholders, while VIVAX's dividend yield for the trailing twelve months is around 2.16%.

The maximum VIGL drawdown since its inception was -91.90%, which is greater than VIVAX's maximum drawdown of -59.38%. Use the drawdown chart below to compare losses from any high point for VIGL and VIVAX.

Vigil Neuroscience, Inc. (VIGL) has a higher volatility of 126.17% compared to Vanguard Value Index Fund (VIVAX) at 4.27%. This indicates that VIGL's price experiences larger fluctuations and is considered to be riskier than VIVAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.